Riders · Board of Pharmacy · Article VIII: Regulatory

Cybersecurity Response Contingency

Rider 5 in the Senate substitute, page VIII-39

This rider is not in the House substitute or any later version.

Through the session

  1. 2024-25 Act Not in this version
  2. Introduced (Senate) Not in this version
  3. Introduced (House) Not in this version
  4. Senate substitute New rider 5
  5. House substitute Dropped
  6. House passed Not in this version
  7. Conference Not in this version
  8. 2026-27 Act Not in this version

Pick any two steps to compare their wording.

Every version: numbers, statuses and source pages
VersionRider Against the version beforeAgainst the current budget Source
2024-25 ActGeneral Appropriations Act, 2024-25 Biennium Not in this version
Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) Not in this version
Introduced (House)House Bill 1 as introduced (LBB recommended, House) Not in this version
Senate substituteCommittee Substitute for Senate Bill 1 5 New New Page VIII-39
House substituteHouse Committee Substitute for Senate Bill 1 Not in this version
House passedSenate Bill 1 as passed the second house Not in this version
ConferenceConference Committee Report for Senate Bill 1 Not in this version
2026-27 ActGeneral Appropriations Act, 2026-27 Biennium Not in this version
Full text of each wording

Senate substitute

Source, page VIII-39

Cybersecurity Response Contingency. Amounts appropriated above include $300,000 in General Revenue Funds in 2026-27 biennium in Strategy C.1.1, Indirect Administration, and 3.0 Full-Time Equivalents (FTE) positions each fiscal year contingent upon a finding of fact by the Board of Pharmacy that additional resources are needed by the department for the agency to respond to a cybersecurity attack. These amounts are exempt from Article VIII, Special Provisions Relating to all Regulatory Agencies, Sec. 2, Appropriations Limited to Revenue Collections. None of the funds appropriated above in Strategy C.1.1 may be expended and none of the 3.0 Full- Time-Equivalents (FTE) positions each fiscal year included above may be used unless the Board of Pharmacy files a finding of fact with the Governor and the Legislative Budget Board (LBB) and neither the Governor nor the LBB issues a written disapproval not later than the 2nd business day after the date the staff of the LBB concludes its review of the findings of fact and forwards those findings of fact along with the conclusions or comments of the LBB staff to the Chair of the House Appropriations Committee, Chair of the Senate Finance Committee, Speaker of the House, and Lieutenant Governor; and the 2nd business day after the receipt of the finding of fact by the Governor.